Patient Case Scenario Debate

Amphetamines work by increasing dopamine and norepinephrine in the brain through the stimulation of their release and the prevention of reuptake. These neurotransmitters strengthen activity in the prefrontal cortex, which regulates attention, focus, and executive functioning. This mechanism makes amphetamines highly effective for addressing the core symptoms of ADHD, particularly in patients struggling with concentration and academic performance (Santos et al., 2021). Clinical trials consistently show strong response rates, with noticeable improvements in behavior and school outcomes often occurring within the first week of therapy. The availability of both immediate-release and extended-release forms provides flexibility, making it easier to match the medication to patient schedules and symptom patterns.

The advantages of amphetamines include rapid onset of action, extensive evidence of effectiveness, and affordability due to generic options. Patients benefit from individualized dosing schedules that allow for better daily functioning (Farhat et al., 2025). However, disadvantages must also be considered, including appetite suppression, insomnia, and potential cardiovascular effects such as elevated blood pressure and increased heart rate. In some patients, amphetamines can also worsen anxiety or cause irritability. Compared to alternatives, methylphenidate provides similar benefits but is often less potent. Alpha adrenergic agonists are better for hyperactivity and sleep issues, but they are not as effective for inattentive symptoms. Non-stimulants, such as atomoxetine, have slower onset and smaller effect sizes, making them less appropriate for immediate relief (Farhat et al., 2025).

Legal, ethical, and social considerations must guide prescribing decisions. Legally, amphetamines are Schedule II controlled substances that require adherence to federal and state prescribing regulations, including prescription monitoring programs (Tsujii et al., 2021). Ethically, clinicians must weigh the clear therapeutic benefits against the risks of misuse or diversion, which makes patient selection, monitoring, and education essential. Socially, stigma surrounding stimulant medications can interfere with patient and family acceptance, reducing adherence and treatment success (Peterson et al., 2024). Education is critical to help families understand that ADHD is a medical condition and that stimulant therapy is evidence-based, not a substitute for parenting. Providing this context promotes adherence, reduces stigma, and fosters shared decision-making that respects patient and family values.

 

 

References

Farhat, L. C., Lannes, A., Del Giovane, C., Parlatini, V., Garcia-Argibay, M., Ostinelli, E. G., & Cortese, S. (2025). Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 12(5), 355–365. https://doi.org/10.1016/S2215-0366(25)00062-8

Peterson, B. S., Trampush, J., Maglione, M., Bolshakova, M., Rozelle, M., Miles, J., & Hempel, S. (2024). Treatments for ADHD in children and adolescents: A systematic review. Pediatrics, 153(4), e2024065787. https://doi.org/10.1542/peds.2024-065787

Santos, G. M., Santos, E. M., Mendes, G. D., Fragoso, Y. D., Souza, M. R., & Martimbianco, A. L. C. (2021). A review of Cochrane reviews on pharmacological treatment for attention-deficit hyperactivity disorder. Dementia & Neuropsychologia, 15(04), 421-427. https://doi.org/10.1590/1980-57642021dn15-040001

Tsujii, N., Usami, M., Naya, N., Tsuji, T., Mishima, H., Horie, J., & Iida, J. (2021). Efficacy and safety of medication for attention-deficit hyperactivity disorder in children and adolescents with common comorbidities: A systematic review. Neurology and therapy, 10(2), 499–522. https://doi.org/10.1007/s40120-021-00249-0

 

CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER

In Week 5, you were assigned by Faculty to argue either the pro (for) or con (against) for a particular medication.  You were also provided information for a patient case study scenario. Week 5 was your opportunity to conduct research for this debate.

This week, you will present and defend your assigned stance (pro or con) and specific medication for your patient case study scenario with your peers. Within the debate, you will also share your perspective on why the alternative medication class would not be appropriate for the patient case scenario.

Support your answers with evidence-based, peer-reviewed scholarly literature.

Note: APA style format with citations and references will apply.

As a reminder, these were the assigned medications:

 
Pro Con
Amphetamine Amphetamine
Methylphenidate Methylphenidate
Alpha Adrenergic Agonist Alpha Adrenergic Agonist
Non-Stimulant Non-Stimulant

 

Published by
superadmin
View all posts